{ "@context": "https://schema.org", "@graph": [ { "@type": "WebPage", "@id": "https://faruqilaw.com/blog/1319/the-meme-stock-defense-how-in-re-cassava-sciences-inc-securities-litigation-could-reshape-securities-fraud-class-actions/#webpage", "url": "https://faruqilaw.com/blog/1319/the-meme-stock-defense-how-in-re-cassava-sciences-inc-securities-litigation-could-reshape-securities-fraud-class-actions/", "name": "The Meme-Stock Defense: How In Re Cassava Sciences, Inc. Securities Litigation Could Reshape Securities Fraud Class Actions", "datePublished": "2026-10-30T18:43:42+00:00", "dateModified": "2026-10-30T18:43:42+00:00", "isPartOf": { "@type": "WebSite", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/" } }, { "@type": "Article", "@id": "https://faruqilaw.com/blog/1319/the-meme-stock-defense-how-in-re-cassava-sciences-inc-securities-litigation-could-reshape-securities-fraud-class-actions/#article", "headline": "The Meme-Stock Defense: How In Re Cassava Sciences, Inc. Securities Litigation Could Reshape Securities Fraud Class Actions", "description": "Can a company escape securities fraud liability by arguing its own investors were too enthusiastic online? That is essentially the argument Cassava Sciences has taken to the Fifth\u2026", "mainEntityOfPage": { "@id": "https://faruqilaw.com/blog/1319/the-meme-stock-defense-how-in-re-cassava-sciences-inc-securities-litigation-could-reshape-securities-fraud-class-actions/#webpage" }, "url": "https://faruqilaw.com/blog/1319/the-meme-stock-defense-how-in-re-cassava-sciences-inc-securities-litigation-could-reshape-securities-fraud-class-actions/", "datePublished": "2026-10-30T18:43:42+00:00", "dateModified": "2026-10-30T18:43:42+00:00", "author": { "@type": "Person", "name": "Braeden Hodges" }, "publisher": { "@id": "https://faruqilaw.com/blog/1319/the-meme-stock-defense-how-in-re-cassava-sciences-inc-securities-litigation-could-reshape-securities-fraud-class-actions/#publisher" }, "image": "https://faruqilaw.com/wp-content/uploads/2025/12/Featured_Image_12.4.2025.png" }, { "@type": "Organization", "@id": "https://faruqilaw.com/blog/1319/the-meme-stock-defense-how-in-re-cassava-sciences-inc-securities-litigation-could-reshape-securities-fraud-class-actions/#publisher", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": { "@type": "ImageObject", "url": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg" }, "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "FAQPage", "@id": "https://faruqilaw.com/blog/1319/the-meme-stock-defense-how-in-re-cassava-sciences-inc-securities-litigation-could-reshape-securities-fraud-class-actions/#faq", "mainEntity": [ { "@type": "Question", "name": "What is the Cassava Sciences securities fraud case about?", "acceptedAnswer": { "@type": "Answer", "text": "Investors allege that between September 2020 and October 2023, Cassava Sciences and its executives misrepresented the integrity of clinical data supporting simufilam, an experimental Alzheimer\u2019s treatment. Part of the allegation is that Cassava said a failed trial had been independently reanalyzed, when the reanalysis was actually done by a conflicted researcher who was later indicted for fraud." } }, { "@type": "Question", "name": "What is the \u201cmeme stock\u201d defense in the Cassava case?", "acceptedAnswer": { "@type": "Answer", "text": "Cassava argues that its stock behaved like a meme stock, with price swings driven by retail enthusiasm and social media rather than by public information. According to Cassava, this made the market inefficient, so investors should not get a presumption that they relied on the integrity of the market price." } }, { "@type": "Question", "name": "What is the Basic presumption of reliance?", "acceptedAnswer": { "@type": "Answer", "text": "Under the Supreme Court\u2019s decision in Basic Inc. v. Levinson, investors who trade in an efficient market are presumed to have relied on a stock price that reflects all public information. They do not each have to prove that they personally read and relied on a specific misstatement." } }, { "@type": "Question", "name": "Why does the Basic presumption matter for securities class actions?", "acceptedAnswer": { "@type": "Answer", "text": "It is what makes securities class actions practical. Without it, thousands of investors would each have to prove individual reliance, which would usually make class certification impossible." } }, { "@type": "Question", "name": "How did the district court rule on Cassava\u2019s meme stock argument?", "acceptedAnswer": { "@type": "Answer", "text": "In an August 2025 order, the Western District of Texas rejected the argument. The court found that Cassava\u2019s own expert could not substantiate the meme-stock characterization and that the traditional efficiency factors supported treating the market as efficient. The court then certified the investor class." } }, { "@type": "Question", "name": "What is the Fifth Circuit deciding in the Cassava appeal?", "acceptedAnswer": { "@type": "Answer", "text": "The Fifth Circuit agreed in October 2025 to hear Cassava\u2019s interlocutory appeal of the class certification order. It heard oral argument in August 2026 and has not yet ruled. It is the first federal appeals court to address how meme-stock trading affects the Basic presumption." } }, { "@type": "Question", "name": "Did Cassava Sciences settle with the SEC?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. The SEC charged Cassava and two executives in 2024, and Cassava paid $40 million to settle those charges." } }, { "@type": "Question", "name": "What happens to the $31.25 million Cassava settlement if the Fifth Circuit reverses?", "acceptedAnswer": { "@type": "Answer", "text": "In December 2025, Cassava agreed to pay $31.25 million to settle the shareholder fraud claims, but the settlement depends on the class certification order surviving appeal. If the Fifth Circuit reverses, the settlement could unravel." } }, { "@type": "Question", "name": "How could the Cassava decision affect retail investors in meme stocks?", "acceptedAnswer": { "@type": "Answer", "text": "If appellate courts accept that heavy social-media-driven trading can by itself defeat market efficiency, companies facing fraud claims over heavily retail-traded stocks could use that to block class certification. Investors would then be pushed into individual lawsuits, which are rarely worth the cost for smaller retail losses." } }, { "@type": "Question", "name": "Is there any merit to Cassava\u2019s meme stock argument?", "acceptedAnswer": { "@type": "Answer", "text": "The defense raises a legitimate theoretical point. Fraud-on-the-market theory assumes that prices absorb public information, so if a stock\u2019s price really reflects social-media sentiment disconnected from disclosed facts, the case for presuming reliance weakens. So far, though, courts have required defendants to back up meme-stock claims with actual evidence rather than accepting the label at face value." } }, { "@type": "Question", "name": "What was the class period in the Cassava Sciences securities fraud lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The proposed investor class covered individuals and entities that purchased or acquired Cassava Sciences securities between September 14, 2020, and October 12, 2023. The lawsuit alleges that misleading statements about the company's experimental Alzheimer's treatment affected investors during this period." } }, { "@type": "Question", "name": "How is simufilam connected to the Cassava Sciences securities litigation?", "acceptedAnswer": { "@type": "Answer", "text": "Simufilam is an experimental Alzheimer's disease treatment developed by Cassava Sciences. Investors allege that the company and certain executives misrepresented the drug's research results and effectiveness, potentially misleading shareholders about its prospects." } }, { "@type": "Question", "name": "Which federal securities laws are involved in the Cassava Sciences lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The lawsuit includes claims under Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. These provisions address securities fraud and, under certain circumstances, the liability of individuals who control companies responsible for securities violations." } }, { "@type": "Question", "name": "Does extreme stock price volatility automatically indicate market inefficiency?", "acceptedAnswer": { "@type": "Answer", "text": "No. Significant stock price fluctuations do not automatically establish that a market is inefficient. However, unusual price movements without corresponding company news may provide relevant evidence when courts evaluate whether stock prices accurately reflect publicly available information." } }, { "@type": "Question", "name": "What are the Cammer and Krogman factors in securities class action litigation?", "acceptedAnswer": { "@type": "Answer", "text": "The Cammer and Krogman factors are indicators courts use to evaluate market efficiency. They include trading volume, analyst coverage, market makers, market capitalization, bid-ask spreads, public float, and how stock prices respond to new information. Courts must consider these factors alongside other relevant evidence." } }, { "@type": "Question", "name": "Why do short-selling restrictions matter in securities fraud class actions?", "acceptedAnswer": { "@type": "Answer", "text": "Short-selling restrictions can make it more difficult for investors to trade on negative information about a company. High borrowing costs or limited share availability may prevent stock prices from fully reflecting adverse information, potentially affecting assessments of market efficiency." } }, { "@type": "Question", "name": "How does expert testimony influence securities fraud class certification?", "acceptedAnswer": { "@type": "Answer", "text": "Economic experts frequently analyze stock price movements, trading activity, and market efficiency during class certification proceedings. Courts evaluate competing expert reports to determine whether investors can establish common reliance on alleged misrepresentations through the fraud-on-the-market theory." } }, { "@type": "Question", "name": "What does Rule 23(b)(3) predominance mean in securities fraud litigation?", "acceptedAnswer": { "@type": "Answer", "text": "Rule 23(b)(3) requires that common legal or factual questions predominate over questions affecting individual class members. In securities fraud cases, establishing market efficiency can help plaintiffs satisfy this requirement by supporting a classwide presumption of investor reliance." } }, { "@type": "Question", "name": "Must a stock be formally classified as a meme stock to challenge market efficiency?", "acceptedAnswer": { "@type": "Answer", "text": "No. Courts must evaluate relevant evidence of market inefficiency even if an economic expert does not expressly label a security as a meme stock. Trading patterns, unexplained price volatility, and short-selling constraints may all be relevant to the analysis." } }, { "@type": "Question", "name": "Did the Fifth Circuit determine whether Cassava Sciences committed securities fraud?", "acceptedAnswer": { "@type": "Answer", "text": "No. The Fifth Circuit's October 2026 decision addressed class certification rather than the ultimate merits of the investors' fraud allegations. The court vacated the certification order and returned the case to the district court for further proceedings." } } ] } ] }

The Meme-Stock Defense: How In Re Cassava Sciences, Inc. Securities Litigation Could Reshape Securities Fraud Class Actions

30 Oct 2026
Last Updated: October 30, 2026

Can a company escape securities fraud liability by arguing its own investors were too enthusiastic online? That is essentially the argument Cassava Sciences has taken to the Fifth Circuit, in a case that could determine whether millions of retail investors in “meme stocks” retain practical access to class-action relief when defrauded. A federal appeals court is now weighing in, for the first time, and the answer will matter well beyond this case.

Cassava Sciences is an Austin-based biopharmaceutical company that was developing simufilam, an experimental Alzheimer’s treatment. Investors allege that between September 2020 and October 2023, Cassava and its executives misrepresented the integrity of clinical data supporting the drug, including by claiming that a failed trial had been independently reanalyzed when that reanalysis was actually performed by a conflicted researcher who was later indicted for fraud. The SEC separately charged the company and two executives in 2024, which Cassava paid $40 million to settle.

In the related shareholder class action, In Re Cassava Sciences, Inc. Securities Litigation, filed in the Western District of Texas, Cassava argued that the court should not presume investors relied upon the integrity of the market price when they traded. Under the Supreme Court’s seminal decision in Basic Inc. v. Levinson, investors in an efficient market are entitled to a presumption that a stock’s price reflects all public information, so they need not each prove they personally read and relied upon a specific misstatement. That presumption is what ensures the practicality of securities class actions—without it, thousands of investors would each have to prove individual reliance.

Cassava fought this presumption, arguing its stock behaved like a “meme stock,” characterized by price swings driven by retail enthusiasm and social media rather than rational absorption of public information, and that this made the market inefficient. The court rejected the argument in an August 2025 order, finding that Cassava’s own expert could not actually substantiate the meme-stock characterization, and that the traditional efficiency factors all supported treating the market as efficient. The court then certified the class of investors.

However, in October 2025, Cassava persuaded the Fifth Circuit to hear an interlocutory appeal of that class certification order. Oral argument took place in August 2026, with no ruling yet issued. Until now, no federal appeals court had previously addressed how meme-stock trading dynamics affect the Basic presumption.

The stakes here are real and immediate. Cassava separately agreed in December 2025 to pay $31.25 million to settle the underlying fraud claims, but that settlement is itself contingent upon the lower court’s class certification order surviving appellate review; if the Fifth Circuit reverses, the settlement could unravel. More broadly, if appellate courts accept that heavy social-media-driven trading activity alone can defeat market efficiency, companies defending against fraud claims tied to heavily retail-traded stocks would gain a powerful new tool to block class certification, forcing investors into costly individual litigation that is rarely economical for smaller retail losses.

On the other hand, the defense raises a legitimate theoretical point: fraud-on-the-market theory rests upon the premise that prices assimilate public information, and if a stock’s price genuinely reflects social-media sentiment untethered from disclosed facts, the economic case for presuming reliance crumbles. As illustrated by the court’s class certification order, courts so far have required defendants to substantiate meme-stock claims with actual evidence rather than accepting the characterization at face value, and the Fifth Circuit’s decision will show whether that evidentiary approach holds up.

Share this post on
About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in Atlanta, Los Angeles and Philadelphia.

Since its founding in 1995, Faruqi & Faruqi, LLP has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, direct purchasers, consumers and employees.

To schedule a free consultation with our attorneys and to learn more about your legal rights, call our offices today at (877) 247-4292 or (212) 983-9330.

About Braeden Hodges

Braeden Hodges is an Associate in Faruqi & Faruqi’s New York City office.  Braeden’s practice is focused on Securities Litigation.

Braeden Hodges
Associate at Faruqi & Faruqi, LLP
New York office
Tel:(212) 983-9330
Fax:(212) 983-9331
E-mail:bhodges@faruqilaw.com
Tags: Basic v. Levinson, Cassava Sciences, Class Action Lawsuit, class certification, Fifth Circuit, Fraud on the Market, Investor Rights, Meme Stocks, Retail Investors, securities fraud

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771